Caesarea, Israel (PRWEB) July 28, 2014
The Journal of Cosmetics, Dermatological Sciences and Applications published in its June 2014 edition a study performed by Israeli Board Certified Dermatologists, Dr. Yoram Harth and Dr. Monica Elman, that examines the safety and efficacy of EndyMed’s new Microneedle Radiofrequency handpiece in the treatment of patients with depressed acne scars.
Twenty patients, fifteen females and five males, were included in the study. The mean age of the participants was 32.6 years. The number of treatments varied between one and six, with an average of 3.3 treatments per patient. The objective evaluation of the patient's improvement showed clear improvement in 95% of patients. Twenty five percent of the participants showed excellent improvement (defined as >75% improvement), an additional 50% experienced good improvement (defined as 26% - 50% improvement), and 20% showed minimal improvement. One patient showed no improvement. None of the patients experienced worsening in their skin condition.
When the patients were asked their opinion about their improvement, 19 out of 20 (95%) of the treated patients reported that they experienced some improvement. Twenty five percent reported that they experienced very good to excellent improvement (defined as >50% improvement), and an additional 30% reported good improvement (defined as 26% - 50% improvement). The rest reported some improvement (up to 25%). Only one patient did not notice any improvement.
The Intensif treatments were very well tolerated by the patients. Using a topical anesthetic cream before the treatment, eleven patients (55%) reported none to minimal pain, six (30%) moderate discomfort and only 3 (15%) reported significant pain.
Combining microneedles with radiofrequency is a skin treatment that is gaining popularity and offers multiple advantages over fractional lasers. As a group , RF microneedles systems allow for significantly deeper penetration of energy into the dermis with a decreased risk of downtime or risk of pigmentary changes in dark skin individuals. The FDA cleared Intensif handpiece by Endymed uses the latest in innovative Microneedle RF technology, and allows for controlled heating to a pre-defined depth (up to 3.5mm) of the dermis without epidermal coagulation. This eliminates most of the micro crusting, reduces the risk of post-inflammatory hyperpigmentation associated with epidermal injury, and allows for the return to normal routine after 24 hours or less.
EndyMed's specially designed smooth motion electronically controlled motor and high quality gold plated needles ensures minimal trauma to the epidermis and significantly decreases discomfort to the patient. These features offer clinical advantages over available fractional lasers and other Microneedle RF technologies.
The presented results prove that EndyMed's microneedle RF technology with electronically controlled smooth insertion motor and non-insulated gold plated needles is a completely safe and effective treatment option for atrophic acne scars, providing a minimally invasive, minimal discomfort and minimal downtime for all skin types. This study shows high objective and subjective satisfaction rates with minimal downtime or adverse effects.
The full article can be found on: http://www.scirp.org/journal/PaperDownload.aspx?paperID=47403.
About EndyMed Medical
EndyMed Medical Ltd., established in 2007, offers energy based aesthetic treatment systems for the professional markets. EndyMed's proprietary 3DEEP® radiofrequency technology is a unique multifunction treatment platform for fractional Skin resurfacing , Microneedle RF technology and non-ablative skin tightening on both the face and body. Through the three dimensional interaction of multiple RF sources, 3DEEP® RF creates deep thermal patterns in the tissue which is a novel and effective approach to aesthetic treatments. For more information, please see our website at http://www.endymed.com.